C1QA and COMP: plasma-based biomarkers for early diagnosis of pancreatic neuroendocrine tumors

C1QA and COMP: plasma-based biomarkers for early diagnosis of pancreatic neuroendocrine tumors

Abstract Pancreatic Neuroendocrine tumors (PanNET) are challenging to diagnose and often detected at advanced stages due to a lack of specific and sensitive biomarkers. This study utilized proteomics as a valuable approach for cancer biomarker discovery; therefore, mass spectrometry-based proteomic...

Full description

Bibliographic Details
Main Authors: Priya Kumari Gorai, Prahalad Singh Bharti, Shashi Kumar, Girish H. Rajacharya, Sabyasachi Bandyopadhyay, Sujoy Pal, Renu Dhingra, Rakesh Kumar, Fredrik Nikolajeff, Saroj Kumar, Neerja Rani
Format: Article
Language:English
Published: Nature Portfolio 2023-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-48323-x

Internet

https://doi.org/10.1038/s41598-023-48323-x

Similar Items